Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma. The EMA’s ...

Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.